New and updated clinical data presented by biopharma firms at the American Association for Cancer Research annual meeting, including: Abclon, Allogene, Avistone, Bold, Cantargia, Convergent, Erasca, Evaxion, Exuma, Imcheck, Immunocore, Innovent, Merck, Moderna.